Clarus Corp (CLAR) is the issuer named in an amended ownership disclosure in which Warren B. Kanders may be deemed to beneficially own 8,124,220 shares as of September 28, 2026, approximately 20.2%. The amount includes 1,905,997 options exercisable or exercisable within 60 days. Kanders GMP Holdings, LLC separately reports 1,528,465 shares, included in—not additional to—Kanders’ total. The percentage calculation uses 38,288,155 shares outstanding as of July 30, 2026, plus Kanders’ option shares.
Warren B. Kanders received previously unavailable margin borrowing capacity on 1,679,147 shares serving as collateral for a Loan Agreement with Bank of America, N.A. The collateral comprises 500,000 shares beneficially owned by Holdings and 1,179,147 beneficially owned by Kanders.
Clarus Corporation reported Q2 2026 sales of $56.2 million, up 1.6% year over year, as strength in Outdoor offset weakness in Adventure. Outdoor sales rose 8.5% to $39.8 million, while Adventure declined 11.9% to $16.4 million amid softer wholesale demand in Australia and North America.
Gross margin expanded to 48.9% from 35.6%, helped by a $6.1 million IEEPA tariff refund and favorable mix, driving net income of $4.7 million (8.4% margin) versus an $8.4 million loss a year earlier. Adjusted net income was $6.8 million and adjusted EBITDA improved to $7.6 million, a 13.6% margin. Free cash flow turned positive at $0.6 million.
The company repurchased 153,331 shares for about $0.4 million and completed the bolt-on acquisition of ONWRD Supply Co., adding high-margin in-vehicle accessories. Management reiterated 2026 sales guidance of $245–$255 million and now expects adjusted EBITDA of $12–$13 million, with Q3 sales projected at $66–$68 million and adjusted EBITDA around $3 million, while a previously announced strategic review of alternatives remains ongoing.
Clarus Corp director Werner Roger received a grant of stock options covering 20,000 shares of common stock. These options have an exercise price of $3.11 per share and were awarded at no cost as a compensation-related grant. They were issued under Clarus’ Amended and Restated 2015 Stock Incentive Plan and will vest in four equal installments of 5,000 shares each on June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027, if service-based conditions are met. Following this grant, Roger holds 20,000 stock options directly, which are scheduled to expire on May 28, 2036 if not exercised.
Clarus Corp director Nicolas Sokolow received a grant of stock options covering 20,000 shares of common stock. The options have an exercise price of $3.11 per share and expire on May 28, 2036. They were granted under Clarus’ Amended and Restated 2015 Stock Incentive Plan.
The award vests in four equal installments of 5,000 options on June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027. Following this grant, Sokolow holds options to purchase 20,000 shares directly. This is a compensation-related grant rather than an open-market purchase or sale.
Clarus Corp director Susan Ottmann received a grant of stock options covering 20,000 shares of common stock. These options have an exercise price of $3.11 per share and expire on May 28, 2036. The grant was made under the company’s Amended and Restated 2015 Stock Incentive Plan.
The options vest in four equal installments of 5,000 shares each, becoming exercisable on June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027. Following this grant, Ottmann holds 20,000 stock options directly.
Clarus Corporation reported the results of its Annual Meeting of Stockholders. Out of 38,441,486 shares of common stock outstanding and entitled to vote, 32,544,653 were present in person or by proxy, representing approximately 84.66% of the shares entitled to vote.
Stockholders elected five directors — Warren B. Kanders, Nicholas Sokolow, Susan Ottmann, Roger Werner, and Mark M. Besca — each to serve until the next annual meeting and until their successors are elected and qualified. They also approved an advisory resolution on executive compensation and ratified the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the year ending December 31, 2026.
Clarus Corp director Mark Besca received a grant of stock options covering 20,000 shares of common stock. The options were awarded at an exercise price of $3.11 per share and were granted at no upfront cost. They expire on May 28, 2036 and were issued under the company’s Amended and Restated 2015 Stock Incentive Plan.
According to the vesting schedule, options for 5,000 shares will vest and become exercisable on each of June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027. After this grant, Besca holds options to purchase 20,000 shares directly.
Clarus Corporation ownership update: Greenhouse Funds LLLP and related Greenhouse entities report shared beneficial ownership of 5,448,431 shares, representing 14.2% of Clarus Corporation common stock. Related entities Greenhouse Fund GP LLC, Greenhouse Master Fund LP, and Greenhouse Long Only Master Fund LP report beneficial holdings of 4,314,706, 1,997,839, and 2,027,088 shares, respectively. The filing lists shared voting and shared dispositive power for these holdings; none of the reporting persons claim sole voting or sole dispositive power. The report is signed by Joseph Milano as authorized person for the filers.